Impact of treatment on cellular immunophenotype in MS: A cross-sectional study (Q90089343)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32139439 AND SRC:MED&resulttype=core&format=json

11 April 2020

title

Impact of treatment on cellular immunophenotype in MS: A cross-sectional study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32139439 AND SRC:MED&resulttype=core&format=json

11 April 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32139439 AND SRC:MED&resulttype=core&format=json

11 April 2020

Matteo Pardini

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32139439 AND SRC:MED&resulttype=core&format=json

11 April 2020

Priscilla Koduah

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32139439 AND SRC:MED&resulttype=core&format=json

11 April 2020

Tone Berge

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32139439 AND SRC:MED&resulttype=core&format=json

11 April 2020

Alice Laroni

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32139439 AND SRC:MED&resulttype=core&format=json

11 April 2020

Caterina Lapucci

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32139439 AND SRC:MED&resulttype=core&format=json

11 April 2020

Giovanni Novi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32139439 AND SRC:MED&resulttype=core&format=json

11 April 2020

Susanna Asseyer

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32139439 AND SRC:MED&resulttype=core&format=json

11 April 2020

Einar A. Høgestøl

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32139439 AND SRC:MED&resulttype=core&format=json

11 April 2020

Cristina Campi

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32139439 AND SRC:MED&resulttype=core&format=json

11 April 2020

Michele Piana

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32139439 AND SRC:MED&resulttype=core&format=json

11 April 2020

Matilde Inglese

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32139439 AND SRC:MED&resulttype=core&format=json

11 April 2020

Friedemann Paul

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32139439 AND SRC:MED&resulttype=core&format=json

11 April 2020

Hanne F Harbo

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32139439 AND SRC:MED&resulttype=core&format=json

11 April 2020

Pablo Villoslada

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32139439 AND SRC:MED&resulttype=core&format=json

11 April 2020

Nicole Kerlero de Rosbo

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32139439 AND SRC:MED&resulttype=core&format=json

11 April 2020

Antonio Uccelli

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32139439 AND SRC:MED&resulttype=core&format=json

11 April 2020

author name string

Federico Ivaldi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32139439 AND SRC:MED&resulttype=core&format=json

11 April 2020

Gianluca Rotta

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32139439 AND SRC:MED&resulttype=core&format=json

11 April 2020

Gemma Vila

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32139439 AND SRC:MED&resulttype=core&format=json

11 April 2020

Giacomo Boffa

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32139439 AND SRC:MED&resulttype=core&format=json

11 April 2020

Elvira Sbragia

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32139439 AND SRC:MED&resulttype=core&format=json

11 April 2020

Serena Palmeri

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32139439 AND SRC:MED&resulttype=core&format=json

11 April 2020

publication date

5 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32139439 AND SRC:MED&resulttype=core&format=json

Neurology(R) neuroimmunology & neuroinflammation

11 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32139439 AND SRC:MED&resulttype=core&format=json

11 April 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32139439 AND SRC:MED&resulttype=core&format=json

11 April 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32139439 AND SRC:MED&resulttype=core&format=json

Loss of functional suppression by CD4 CD25 regulatory T cells in patients with multiple sclerosis

11 April 2020

cites work

1 reference

12 December 2020

Immune surveillance in multiple sclerosis patients treated with natalizumab.

1 reference

12 December 2020

Fingolimod and sphingosine-1-phosphate--modifiers of lymphocyte migration

1 reference

12 December 2020

Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis.

1 reference

12 December 2020

Natural naive CD4 CD25 CD127low regulatory T cell (Treg) development and function are disturbed in multiple sclerosis patients: recovery of memory Treg homeostasis during disease progression.

1 reference

12 December 2020

T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta.

1 reference

12 December 2020

Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis

1 reference

12 December 2020

Modulation of the central memory and Tr1-like regulatory T cells in multiple sclerosis patients responsive to interferon-beta therapy

1 reference

12 December 2020

The problems and promises of research into human immunology and autoimmune disease

1 reference

12 December 2020

Standardizing immunophenotyping for the Human Immunology Project

1 reference

12 December 2020

Translational applications of flow cytometry in clinical practice.

1 reference

12 December 2020

Systemic inflammation in progressive multiple sclerosis involves follicular T-helper, Th17- and activated B-cells and correlates with progression

1 reference

12 December 2020

Fingolimod modulates peripheral effector and regulatory T cells in MS patients.

1 reference

12 December 2020

Changes in Th17 and regulatory T cells after fingolimod initiation to treat multiple sclerosis

1 reference

12 December 2020

The effect of glatiramer acetate therapy on functional properties of B cells from patients with relapsing-remitting multiple sclerosis.

1 reference

12 December 2020

Reduction of CD8( ) T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate

1 reference

12 December 2020

Fingolimod treatment promotes regulatory phenotype and function of B cells

1 reference

12 December 2020

Immune biomarkers: the promises and pitfalls of personalized medicine.

1 reference

12 December 2020

HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammation

1 reference

12 December 2020

Multiparametric flow cytometric analysis of whole blood reveals changes in minor lymphocyte subpopulations of multiple sclerosis patients.

1 reference

12 December 2020

Standardizing Flow Cytometry Immunophenotyping Analysis from the Human ImmunoPhenotyping Consortium

1 reference

12 December 2020

Dimethyl fumarate treatment of relapsing-remitting multiple sclerosis influences B-cell subsets

1 reference

12 December 2020

Immunologic profiles of multiple sclerosis treatments reveal shared early B cell alterations

1 reference

12 December 2020

Current multiple sclerosis treatments have improved our understanding of MS autoimmune pathogenesis

1 reference

12 December 2020

The topographical model of multiple sclerosis: A dynamic visualization of disease course

1 reference

12 December 2020

Circulating immune cells in multiple sclerosis.

1 reference

12 December 2020

Alemtuzumab treatment alters circulating innate immune cells in multiple sclerosis

1 reference

12 December 2020

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

1 reference

12 December 2020

Treatment response to dimethyl fumarate is characterized by disproportionate CD8 T cell reduction in MS.

1 reference

12 December 2020

Both cladribine and alemtuzumab may effect MS via B-cell depletion

1 reference

12 December 2020

The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations

1 reference

12 December 2020

Towards personalized therapy for multiple sclerosis: prediction of individual treatment response.

1 reference

12 December 2020

Rebooting Human Immunology.

1 reference

12 December 2020

1 reference

12 December 2020

Reassessing B cell contributions in multiple sclerosis

1 reference

12 December 2020

Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors

1 reference

12 December 2020

Memory B Cells Activate Brain-Homing, Autoreactive CD4 T Cells in Multiple Sclerosis

1 reference

12 December 2020

Dimethyl fumarate as a first- vs second-line therapy in MS: Focus on B cells

1 reference

12 December 2020

Teriflunomide treatment for multiple sclerosis modulates T cell mitochondrial respiration with affinity-dependent effects

1 reference

12 December 2020